Expression of cyclooxygenase-2 in colonic polyps

Polskie Archiwum Medycyny Wewnetrznej

Volumn 120, Issue 9, 2010, Pages 313-320

  Wasilewicz, Michał P ^a,b   Kołodziej, Blanka ^a   Bojułko, Teresa ^a   Kaczmarczyk, Mariusz ^a   Sulzyc Bielicka, Violetta ^a   Bielicki, Dariusz ^a  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

^b Marie Curie Hospital   (Poland)

Author keywords

Carcinogenesis; Colonic polyps; Cyclooxygenase 2; Immunohistochemistry

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; MONOCLONAL ANTIBODY; PTGS2 PROTEIN, HUMAN; TUMOR MARKER;

ADENOMA; ADULT; AGED; ARTICLE; CANCER RISK; CANCER STAGING; CLINICAL EXAMINATION; COLON CARCINOGENESIS; COLON POLYP; CONTROLLED STUDY; DISEASE ASSOCIATION; DYSPLASIA; EPITHELIUM; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; RISK FACTOR; STAINING; ADENOCARCINOMA; COLON; COLORECTAL TUMOR; EARLY DIAGNOSIS; ENZYMOLOGY; INTESTINE MUCOSA; METABOLISM; MIDDLE AGED; PATHOLOGY; POLAND; STROMA CELL;

ADENOCARCINOMA; ADENOMA; ADULT; AGED; COLON; COLONIC POLYPS; COLORECTAL NEOPLASMS; CYCLOOXYGENASE 2; EARLY DIAGNOSIS; EPITHELIUM; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTESTINAL MUCOSA; MALE; MIDDLE AGED; POLAND; STROMAL CELLS; TUMOR MARKERS, BIOLOGICAL;

EID: 79952115048     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: 10.20452/pamw.955     Document Type: Article

References (38)

1. Wojciechowska U, Didkowska J, Zatoński W. Malignant tumors in Poland in 2006. Warszawa, Poland: M. Sklodowska-Curie Center for Oncology; 2008.
2. Hauser SC, Pardi DS, Poterucha JJ. Mayo Clinic gastroenterology and hepatology board review. Rochester, NY: Mayo Clinic Scientific Press - Taylor & Francis Group; 2006.
3. Stryer L. Biochemistry. New York, NY: W.H. Freeman & Company; 1995: 665-669.
4. Kumar V, Cotran RS, Robbins SL. Basic Pathology. Wroclaw, Poland: Urban & Partner; 2005: 43-77.
5. Chen WS, Wei SJ, Liu JM, et al. Tumor invasiveness and liver metastasis of colon cancer cells correlated with cyclooxygenase-2 (COX-2) expression and inhibited by a COX-2-selective inhibitor, etodolac. Int J Cancer. 2001; 91: 894-899. (Pubitemid 32178662)
6. Kutchera W, Jones DA, Matsunami N, et al. Prostaglandin H synthase 2 is expressed abnormally in human colon cancer: evidence for a transcriptional effect. Proc Natl Acad Sci U S A. 1996; 93: 4816-4820. (Pubitemid 26162834)
7. Soslow RA, Dannenberg AJ, Rush D, et al. COX-2 is expressed in human pulmonary, colonic and mammary tumors. Cancer. 2000; 89: 2637-2645. (Pubitemid 32011609)
8. DuBois RN. Review article: cyclooxygenase - a target for colon cancer prevention. Aliment Pharmacol Ther. 2000; 14: 64-67.
9. Chapple KS, Cartwright EJ, Hawcroft G, et al. Localization of cyclooxygenase-2 in human sporadic colorectal adenomas. Am J Pathol. 2000; 156: 545-553. (Pubitemid 30643810)
10. Fujita M, Fukui H, Kusaka T, et al. Relationship between cyclooxygenase-2 expression and K-ras gene mutation in colorectal adenomas. J Gastroenterol Hepatol. 2000; 15: 1277-1281.
11. Wu AW, Gu J, Ji JF, et al. Role of COX-2 in carcinogenesis of colorectal cancer and its relationship with tumor biological characteristics and patients' prognosis. World J Gastroenterol. 2003; 9: 1990-1994. (Pubitemid 37168428)
12. Khan KN, Masferrer JL, Woerner BM, et al. Enhanced cyclooxygenase-2 expression in sporadic and familial adenomatous polyposis of the human colon. Scand J Gastroenterol. 2001; 36: 865-869. (Pubitemid 32656562)
13. Masunaga R, Kohno H, Dhar DK, et al. Cyclooxygenase-2 expression correlates with tumor neovascularization and prognosis in human colorectal carcinoma patients. Clin Cancer Res. 2000; 6: 4064-4068.
14. Pisano C, Ottaiano A, Tatangelo F, et al. Cyclooxygenase-2 expression is associated with increased size in human sporadic colorectal adenomas. Anticancer Res. 2005; 25: 2065-2068. (Pubitemid 40904605)
15. Tatsu K, Hayashi S, Shimada I, et al. Cyclooxygenase-2 in sporadic colorectal polyps: immunohistochemical study and its importance in the early stages of colorectal tumorigenesis. Pathol Res Pract. 2005; 201: 427-433. (Pubitemid 41093720)
16. Chan AT, Giovannucci EL, Meyerhardt JA, et al. Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer. JAMA. 2005; 294: 914-923. (Pubitemid 41215460)
17. Sandler RS, Halabi S, Baron JA, et al. A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer. N Engl J Med. 2003; 348: 883-890. (Pubitemid 36297996)
18. Zhang H, Sun XF. Overexpression of cyclooxygenase-2 correlates with advanced stages of colorectal cancer. Am J Gastroenterol. 2002; 97: 1037-1041. (Pubitemid 34408266)
19. Einspahr JG, Krouse RS, Yochim JM, et al. Association between cyclooxygenase expression and colorectal adenoma characteristics. Cancer Res. 2003; 63: 3891-3893. (Pubitemid 36917900)
20. Azumaya M, Kobayashi M, Ajioka Y, et al. Size-dependent expression of cyclooxygenase-2 in sporadic colorectal adenomas relative to adenomas in patients with familial adenomatous polyposis. Pathol Int. 2002; 52: 272-276. (Pubitemid 34587812)
21. Fujita T, Matsui M, Takaku K, et al. Size- and invasion-dependent increase in cyclooxygenase 2 levels in human colorectal carcinomas. Cancer Res. 1998; 58: 4823-4826. (Pubitemid 28503676)
22. Petersen S, Haroske G, Hellmich G, et al. COX-2 expression in rectal carcinoma: immunohistochemical pattern and clinical outcome. Anticancer Res. 2002; 22: 1225-1230. (Pubitemid 34836179)
23. Sheehan KM, Sheahan K, O'Donoghue DP, et al. The relationship between cyclooxygenase-2 expression and colorectal cancer. JAMA. 1999; 282: 1254-1257.
24. Hao X, Bishop AE, Wallace M, et al. Early expression of cyclooxygenase-2 during sporadic colorectal carcinogenesis. J Pathol. 1999; 187: 295-301. (Pubitemid 29064154)
25. Xiong B, Sun TJ, Yuan HY, et al. Cyclooxygenase-2 expression and angiogenesis in colorectal cancer. World J Gastroenterol. 2003; 9: 1237-1240. (Pubitemid 36805659)
26. Jass JR. Hyperplastic polyps and colorectal cancer: is there a link? Clin Gastroenterol Hepatol. 2004; 2: 1-8.
27. Jass JR, Whitehall VL, Young J, Leggett BA. Emerging concepts in colorectal neoplasia. Gastroenterology. 2002; 123: 862-876. (Pubitemid 34977092)
28. Kambara T, Simms LA, Whitehall VL. BRAF mutation and CpG island methylation: an alternative pathway to colorectal cancer. Gut. 2004; 53: 1137-1144.
29. Biemer-Hüttmann AE, Walsh MD, McGuckin MA, et al. Mucin core protein expression in colorectal cancers with high levels of microsatellite instability indicates a novel pathway of morphogenesis. Clin Cancer Res. 2000; 6: 1909-1916. (Pubitemid 30305089)
30. Hawkins NJ, Ward RL. Sporadic colorectal cancers with microsatellite instability and their possible origin in hyperplastic polyps and serrated adenomas. J Natl Cancer Inst. 2001; 93: 1307-1313. (Pubitemid 32910571)
31. Goldstein NS, Bhanot P, Odish E, et al. Hyperplastic-like colon polyps that preceded microsatellite unstable adenocarcinomas. Am J Clin Pathol. 2003; 119: 778-796. (Pubitemid 37047838)
32. Elder DJ, Baker JA, Banu NA, et al. Human colorectal adenomas demonstrate a size-dependent increase in epithelial cyclooxygenase-2 expression. J Pathol. 2002; 198: 428-434. (Pubitemid 35446995)
33. Kim SH, Lee JH, Kang KH, et al. [Cyclooxygenase-2 expression according to size and location of gastric and colorectal tubular adenomas]. Korean J Gastroenterol. 2004; 44: 206-211. Korean.
34. Bamba H, Ota S, Kato A, et al. High expression of cyclooxygenase-2 in macrophages of human colonic adenoma. Int J Cancer. 1999; 83: 470-475. (Pubitemid 29489860)
35. Hardwick JC, van den Brink GR, Offerhaus GJ, et al. NF-kappaB, p38 MAPK and JNK are highly expressed and active in the stroma of human colonic adenomatous polyps. Oncogene. 2001; 20: 819-827. (Pubitemid 32198175)
36. Tanaka S, Tatsuguchi A, Futagami S, et al. Monocyte chemoattractant protein 1 and macrophage cyclooxygenase 2 expression in colonic adenoma. Gut. 2006; 55: 54-61. (Pubitemid 41820636)
37. Arnoletti JP, Upson J, Babb JS, et al. Differential stromal and epithelial localization of cyclooxygenase-2 (COX-2) during colorectal tumorigenesis. J Exp Clin Cancer Res. 2005; 24: 279-287. (Pubitemid 41039613)
38. Dixon DA, Kaplan CD, McIntyre TM, et al. Post-transcriptional control of cyclooxygenase-2 gene expression. The role of the 3′-untranslated region. J Biol Chem. 2000; 275: 11 750-11 757.